Our CEO, Peng Fu, and Chief Policy and Partnerships Officer @richardgold.bsky.social are in Paris this week for the OECD Workshop on Open Science and Innovation Partnerships. We’re excited to hear how the discussions unfold and to learn from the insights and lessons emerging from the workshop!

TRIDENT Preclinical Trials@tridentpct.bsky.social · 4mo ago

Great morning representing #TRIDENT & @westernu.ca at the @oecd-ocde.bsky.social Open Science & Innovation Partnerships Workshop: bringing global leaders together to turn research into real-world impact. Big thanks to #NFRF + @conscience-network.bsky.social for making this possible!🤝🌍

We're pleased to share Conscience's first Annual Report! In 2025, we made significant progress in advancing open science drug discovery by funding projects, expanding the CACHE Challenges, providing advisory services, and launching BEACON. Read the report here: conscience.ca/reports/

Reports - Conscience

Conscience Annual Reports 2025 Conscience’s first Annual Report highlights our progress in advancing open science drug discovery, from early-stage research through to clinical translation, while stren...

conscience.ca

Drug discovery is becoming slower and more expensive, but collaboration, and open science can change that. In this new op-ed, Conscience CEO Peng Fu and @estrid-j.bsky.social argue that the real breakthroughs will come from rethinking how science gets done. 🔗 www.ddw-online.com/from-risk-to...

From risk to resilience - Drug Discovery World (DDW)

Peng Fu, CEO, and Estrid Jakobsen, Communications Lead at Conscience, explore how creativity and open science are transforming drug discovery.

ddw-online.com

On Oct 16, @dylan-re.bsky.social and @richardgold.bsky.social will be hosting an infosession on our Open Science Advisory Services program, which provides funding to help you hire the expertise you need for your open science project. Learn more and register here: conscience.ca/event/open-s...

The deadline to apply for CACHE Challenge #7 has been extended to October 10! This challenge focuses on discovering selective inhibitors of PGK2, a promising target for non-hormonal contraception. 🇨🇦 Canadian participants can access reimbursement funds! Learn more here: conscience.ca/event/cache7/

⏳Just a few days left to apply to join CACHE Challenge #7: Finding selective inhibitors of PGK2 for non-hormonal contraception. Don't miss this chance to test your models with high-quality experimental data! Deadline: September 15, 2025 Learn more and apply here: conscience.ca/event/cache7/

CACHE Challenge #7: Finding selective inhibitors of PGK2 for non-hormonal contraception - Conscience

We’re pleased to launch the seventh CACHE Challenge, which is now accepting applications. The deadline to apply is September 15, 2025. The CACHE Challenges, made possible by the Government of Canada’s...

conscience.ca

This new op-ed by @richardgold.bsky.social describes how sequencing #OpenScience before #IntellectualProperty companies can accelerate innovation while reducing cost and risk. It features our CACHE Challenges as an example of an open science initiative that can greatly benefit participating SMEs!

E. Richard Gold@richardgold.bsky.social · last yr.

Simplistic models of #IntellectualProperty get in the way of building a biopharmaceutical company. Here I discuss how going #OpenScience can lead to proprietary rights later on: www.lifescienceleader.com/doc/open-sci... @conscience-network.bsky.social @tridentpct.bsky.social

Are you leading an #OpenScience initiative advancing the field of #neuroscience? Don’t miss this opportunity to be recognized for your contributions. Submit your application for the Neuro-Irv and Helga Cooper Foundation Open Science Prizes today! 👉Apply now! -link in comments #neurology #datasharing

In this op-ed, @richardgold.bsky.social and co-authors argue that Canada must take advantage of instability in U.S. research funding by rethinking how universities support innovation - shifting away from patents toward long-term partnerships and open science. www.nationalobserver.com/2025/07/11/o...

Canadian universities must do a better job encouraging private sector research

Canadian universities have an excellent track record of creating and preserving knowledge, but a poor one for helping innovators to develop products and services.

nationalobserver.com

CACHE4 results are out! All previously known CBLCB ligands shared the same scaffold. Congrats to Keunwan Park who successfully designed a chemically novel series, to the experimental team at @thesgc.bsky.social and thanks to @conscience-network.bsky.social for greasing the wheels! bit.ly/4mYNe3r

🚨 Results of CACHE Challenge #4 are in! 🚨 This challenge focused on identifying novel hits for CBLB, a cancer immunotherapy target that has so far proven difficult to identify novel chemical scaffold for. Read the press release here: conscience.ca/news/cache-c...

CACHE Challenge #4 identifies a novel 'hit' for a cancer immunotherapy target  - Conscience

In our fourth CACHE Challenge, researchers from across the globe used computational methods to predict molecules to bind CBLB, a cancer immunotherapy target. The top-performing team identified a molec...

conscience.ca

Are you working on an open science drug discovery project that could benefit from expert advice on innovation, IP, commercialization, or business planning? Our new Open Science Advisory Services program helps you hire third-party advisors to move your work forward. 🔗 conscience.ca/open-science...

Open Science Advisory Services (OSAS) - Conscience

About OSAS The Open Science Advisory Services (OSAS) program provides funding to organizations and companies seeking third party advisory services related to advancing open science drug discovery. The...

conscience.ca

If you weren’t able to attend our Symposium on Open Drug Discovery in Montreal in April, you’re in luck - the recordings are now on YouTube and the slides are on Zenodo! 🎥 Watch the recordings: www.youtube.com/playlist?lis... 📄 Access the slides: zenodo.org/communities/...

Conscience Symposium on Open Drug Discovery 2025 - YouTube

Recordings of the talks that took place at the Conscience Symposium on Open Drug Discovery on April 7-8, 2025 in Montreal.

youtube.com

✨ Big news! ✨ We’re thrilled to welcome Peng Fu as our new CEO. Peng brings deep experience across biotech, finance, and law, and we’re looking forward to seeing how his leadership brings us closer to a future where no patient is left behind. 🔗 Read the press release: conscience.ca/news/peng-fu...

Peng Fu Appointed CEO of Conscience - Conscience

We’re excited to announce that Peng Fu has joined Conscience as our new Chief Executive Officer. He brings deep experience in biotech, finance, and law, and we’re looking forward to seeing how his lea...

conscience.ca

New from me & @vanbergheneu.bsky.social‬: Canada has a chance to lead on AI policy and data governance at the 2025 G7 Leaders’ Summit theconversation.com/canada-has-a...

Canada has a chance to lead on AI policy and data governance at the 2025 G7 Leaders’ Summit

Canada must back its rhetoric on AI and digital innovation with action that resonates at home and abroad.

theconversation.com

YCharos is an innovative #OpenScience project led by researchers at The Neuro. Its data are now openly available on F1000 Research. Learn how YCharos is improving antibody validation by attending this free webinar on May 29.

Microsoft Virtual Events Powered by Teams

Microsoft Virtual Events Powered by Teams

events.teams.microsoft.com

Can open science fuel growth? In Canadian SME Magazine, our @richardgold.bsky.social argues it can—offering a lower-cost, collaborative path for early-stage innovation. Read it here: canadiansme.ca/canadian-sme...

We’re still energized after the 2025 Conscience Symposium on Open Drug Discovery earlier this month! Thank you to everyone who joined us in Montreal to explore how open science is shaping the future of drug discovery. Check out highlights and photos from the event: conscience.ca/news/reflect...

Reflecting on the Conscience Symposium on Open Drug Discovery - Conscience

The 2025 Conscience Symposium on Open Drug Discovery took place in Montreal on April 7 and 8, 2025, at the Society for Arts and Technology—and we’re proud to share that it was a great success! 126 val...

conscience.ca

The future of AI-drug discovery hinges on large, high-quality, standards-based datasets. No country or firm can build this alone. We need to construct datasets together in the open: www.science.org/doi/10.1126/... @tridentpct.bsky.social @conscience-network.bsky.social @mcgilluniversity.bsky.social

AI drug development’s data problem

The future of drug discovery may be artificial intelligence (AI), but its present is not. AI is in its infancy in the field. To help AI mature, developers need nonproprietary, open, large, high-qualit...

science.org

Great first day of the @conscience-network.bsky.social Symposium on Open Drug Discovery in MTL ✨️ Highlight was catching @dereklowe.bsky.social present a wonderful keynote – super exciting after following his blog and insights for many years! See ya tomorrow for day 2! 🧠

Machine learning does not create knowledge, says Derek Lowe at #ConscienceSymposium2025 @conscience-network.bsky.social

Anke Mueller-Fahrnow, Chair of @conscience-network.bsky.social Board, open the #ConscienceSymposium2025 in Montreal

We've extended the registration deadline for our Symposium on Open Drug Discovery until the start of the event on Monday! Register now for an exciting program of talks, panels, and workshops showcasing how open science and innovation are driving drug discovery. event.fourwaves.com/consciencesy...

Conscience Symposium on Open Drug Discovery

Fourwaves - Conscience Symposium on Open Drug Discovery

event.fourwaves.com

✨New session✨ at our Symposium on Open Drug Discovery: Developing Medicines through Open Science (DMOS) Funded Project Presentations. Featuring Peter Sampson, Sonya MacParland, this session will highlight the first three projects funded by the DMOS program Register here: conscience.ca/symposium2025

New Globe and Mail op-ed by @conscience-network.bsky.social and TRIDENT lead Dr. Richard Gold, "The Key to Winning the Trade War is Doubling Down on Research," linked via our site Open Sci Pubs page linked here 👇🌎🗞️: www.tridentpreclinicaltrials.org/oapubs #NFRF #openscience #research #TRIDENT

🚀One week left to register for our Symposium on Open Drug Discovery! Join us in Montreal April 7-8 for an exciting program showcasing how open science and AI are driving drug discovery. Some sessions are already sold out, so register now! Register by April 2nd: conscience.ca/symposium2025

Conscience Symposium on Open Drug Discovery - Submission and registration are open! - Conscience

Registration is now open for the second annual Conscience Symposium on Open Drug Discovery! Join us at the Society for Arts and Technology in Montreal on April 7-8, 2025, for two days of insightful ta...

conscience.ca

✨ Symposium session reveal ✨ AI-assisted Drug Discovery: Benchmarking the Field - Gustavo Stolovitzky and @caswognum.nl will explore how benchmarking can drive better, more reliable AI tools for drug discovery and biomedicine. Learn more and register here: conscience.ca/symposium2025

✨ Symposium session reveal ✨ Our keynote speaker, @dereklowe.bsky.social will give a talk entitled “AI-assisted Drug Discovery: Reality and Expectations”, providing a no-nonsense look at the role of AI in drug discovery. Learn more and register here: conscience.ca/symposium2025

✨ Symposium session reveal ✨ Innovating Openly: Balancing Open Science and IP in Drug Discovery - @richardgold.bsky.social will dispel the myth that market exclusivity and open sharing are incompatible. Learn more and register here: conscience.ca/symposium2025

Do you believe that #AI will transform #DrugDiscovery and are you tired of seeing new medicines for #RareDiseases or infectious diseases shelved? Don’t miss our Symposium on Open Drug Discovery, April 7-8, 2025 in Montreal! Learn more and register by April 2nd: event.fourwaves.com/consciencesy...